Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Active, not recruiting · NCT04774445 · Registry updated 2025-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cancer, disease susceptibility, inherited disease susceptibility, neoplasm | Active, not recruiting | Not applicable | 2025-02-10 | NCT04774445 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 137 |
| American Cancer Society, Inc. | 60 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center at the University of Pennsylvania | Philadelphia | United States | 8 |